Official PPA Removal From Market Sought In FDA Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
FDA would "assure the removal" of OTC drugs containing phenylpropanolamine (PPA) from the market and "prohibit future marketing of such products" under a proposed rule published in the Federal Register Dec. 22
You may also be interested in...
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary